Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-β-Glycyrrhetinic Acid by Albumin-conjugated PLGA Nanoparticles

Drug Research

Volumn 65, Issue 12, 2015, Pages 617-623

  Darvishi, B ^a,b   Manoochehri, S ^a,b   Esfandyari Manesh, M ^b,c   Samadi, N ^a   Amini, M ^a   Atyabi, F ^a,b   Dinarvand, R ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

18 glycyrrhetinic acid; albumin conjugation; antibacterial effect; PLGA nanoparticles; toxicity

Indexed keywords

18 BETA GLYCYRRHETINIC ACID; ACETONE; ALBUMIN CONJUGATE; DITHIOTHREITOL; GLYCYRRHETINIC ACID DERIVATIVE; HUMAN SERUM ALBUMIN; POLYGLACTIN; UNCLASSIFIED DRUG; ALBUMINOID; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DRUG CARRIER; GLYCYRRHETINIC ACID; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISULFIDE BOND; DRUG CONJUGATION; GLASS TRANSITION TEMPERATURE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ZETA POTENTIAL; CHEMISTRY; DRUG RELEASE; DRUG SCREENING; MICROBIAL SENSITIVITY TEST;

ALBUMINS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG LIBERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLYCYRRHETINIC ACID; HEP G2 CELLS; HUMANS; LACTIC ACID; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; POLYGLYCOLIC ACID;

EID: 84947914340     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1390487     Document Type: Article

References (29)

1. Liang H. F., Yang T. F., Huang C. T. et al. Preparation of nanoparticles composed of poly (γ-glutamic acid)-poly (lactide) block copolymers and evaluation of their uptake by HepG2 cells. Journal of controlled release: 2005; 105 213 225
2. Fattal E., Rojas J., Youssef M. et al. Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrobial agents and chemotherapy: 1991; 35 770 772
3. Couvreur P., Fattal E., Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharmaceutical research: 1991; 8 1079 1086
4. Gulyaev A., Ermekbaeva B. A., Kivman G. Y. et al. Nanoparticles as a vector for the directed delivery of antibiotics (a review). Pharmaceutical chemistry journal: 1998; 32 115 118
5. Yoo H. S., Oh J. E., Lee K. H. et al. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Pharmaceutical research: 1999; 16 1114 1118
6. Dinarvand R., Sepehri N., Manoochehri S. et al. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. International journal of nanomedicine: 2011; 6 877
7. Danhier F., Ansorena E., Silva J. M. et al. PLGA-based nanoparticles: an overview of biomedical applications. Journal of Controlled Release: 2012; 161 505 522
8. Maeda H., Wu J., Sawa T. et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of controlled release: 2000; 65 271 284
9. Taheri A., Atyabi F., Nouri F. S. et al. Nanoparticles of conjugated methotrexate-human serum albumin: preparation and cytotoxicity evaluations. Journal of Nanomaterials: 2011; 2011 5
10. Elzoghby A. O., Samy W. M., Elgindy N. A. Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release: 2012; 157 168 182
11. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release: 2008; 132 171 183
12. Alexopoulos A., Kimbaris A. C., Plessas S. et al. Antibacterial activities of essential oils from eight Greek aromatic plants against clinical isolates of Staphylococcus aureus. Anaerobe: 2011; 17 399 402
13. Reiter K. C., Sant'Anna F. H., d'Azevedo P. A. Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms. International journal of antimicrobial agents: 2014; 43 248 253
14. Carmeli Y., Troillet N., Eliopoulos G. M. et al. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrobial agents and chemotherapy: 1999; 43 1379 1382
15. Nitalikar M. M., Munde K. C., Dhore B. V. et al. Studies of antibacterial activities of Glycyrrhiza glabra root extract. Int J Pharm Tech Res: 2010; 2 899 901
16. Lee C. S., Kim Y. J., Lee M. S. et al. 18β-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity. Life sciences: 2008; 83 481 489
17. Kashi TS J., Eskandarion S., Esfandyari-Manesh M. et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. International journal of nanomedicine: 2012; 7 221
18. Adibkia K., Shadbad MR S., Nokhodchi A. et al. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. Journal of drug targeting: 2007; 15 407 416
19. Manoochehri S., Darvishi B., Kamalinia G. et al. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru: 2013; 1 58
20. Mohammadi G., Valizadeh H., Barzegar-Jalali M. et al. Development of azithromycin-PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids and Surfaces B: Biointerfaces: 2010; 80 34 39
21. Michnik A., Michalik K., Kluczewska A. et al. Comparative DSC study of human and bovine serum albumin. Journal of thermal analysis and calorimetry: 2006; 84 113 117
22. Senthilkumar M., Mishra P., Jain N. K. Long circulating PEGylated poly (D, L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. Journal of drug targeting: 2008; 16 424 435
23. Chorny M., Fishbein I., Danenberg H. D. et al. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release: 2002; 83 389 400
24. Mainardes R. M., Evangelista R. C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. International journal of pharmaceutics: 2005; 290 137 144
25. Mainardes R. M., Gremião MP D., Evangelista R. C. Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Revista Brasileira de Ciências Farmacêuticas: 2006; 42 523 530
26. Panyam J., Labhasetwar V. Dynamics of endocytosis and exocytosis of poly (D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharmaceutical research: 2003; 20 212 220
27. Koopaei M. N., Maghazei M. S., Mostafavi S. H. et al. Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles. DARU Journal of Pharmaceutical Sciences: 2012; 20 92
28. Das S., Suresh P. K., Desmukh R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine: 2010; 6 318 323
29. Mishra B., Patel B. B., Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: Nanotechnology, biology and medicine: 2010; 6 9 24